Arimichi Kamata, Koji Hino, Kenichi Tazawa, Kimiko Kawai, Keiichi Arai, Atsushi Nakano
{"title":"Complete recovery from pseudocirrhosis caused by chemotherapy for diffuse liver metastases of breast cancer.","authors":"Arimichi Kamata, Koji Hino, Kenichi Tazawa, Kimiko Kawai, Keiichi Arai, Atsushi Nakano","doi":"10.1007/s13691-025-00759-w","DOIUrl":null,"url":null,"abstract":"<p><p>Pseudocirrhosis refers to morphologic changes of the liver seen radiographically that mimic cirrhosis and arise in the setting of metastatic malignancy. Like true cirrhosis, pseudocirrhosis causes portal hypertension, which can lead to complications such as ascites and esophageal varices. We experienced a case of pseudocirrhosis that occurred during treatment for diffuse liver metastases from breast cancer. Pseudocirrhosis is often caused by diffuse hepatic cancer cell infiltration; however, in this case, it still occurred despite chemotherapy being effective. The shrinkage of liver metastases and subsequent scarring around them causes liver capsule regression, resulting in pseudocirrhotic changes. As a result of treatment for pseudocirrhosis, the once-atrophied liver regenerated and returned to its normal size after a year. Ascites and edema as portal pressure complications also disappeared. During this time, the liver metastases maintained a near-complete response. Cirrhosis accompanied by ascites is usually called \"decompensated cirrhosis\" and is considered difficult to improve; however, in pseudocirrhosis, the liver can regenerate and the patient can recover. Physicians must be fully aware of this disease.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"14 3","pages":"241-245"},"PeriodicalIF":0.5000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12229408/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Cancer Conference Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13691-025-00759-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pseudocirrhosis refers to morphologic changes of the liver seen radiographically that mimic cirrhosis and arise in the setting of metastatic malignancy. Like true cirrhosis, pseudocirrhosis causes portal hypertension, which can lead to complications such as ascites and esophageal varices. We experienced a case of pseudocirrhosis that occurred during treatment for diffuse liver metastases from breast cancer. Pseudocirrhosis is often caused by diffuse hepatic cancer cell infiltration; however, in this case, it still occurred despite chemotherapy being effective. The shrinkage of liver metastases and subsequent scarring around them causes liver capsule regression, resulting in pseudocirrhotic changes. As a result of treatment for pseudocirrhosis, the once-atrophied liver regenerated and returned to its normal size after a year. Ascites and edema as portal pressure complications also disappeared. During this time, the liver metastases maintained a near-complete response. Cirrhosis accompanied by ascites is usually called "decompensated cirrhosis" and is considered difficult to improve; however, in pseudocirrhosis, the liver can regenerate and the patient can recover. Physicians must be fully aware of this disease.
期刊介绍:
This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO).
- Presents an online-only collection of original case reports on all types of cancer
- In particular, welcomes molecularly analyzed cancer cases
- The Official Publication of the Japan Society of Clinical Oncology (JSCO)